FOXA1 and breast carcinoma: Zhao ranran et al. recently developed a combination therapy using multi-functional cationic porphyrin microbubbles (CpMBs) for dual delivery FOXA1 siRNA and photosensitizer (porphyrin) in ER-positive breast cancer, resulting in significantly ER+ breast tumor growth inhibition and recurrence [173].